Aspartoacylase-3 inhibitors represent a collective term for chemicals that indirectly modulate the activity of the enzyme aspartoacylase-3. Aspartoacylase-3 plays a role in the deacetylation of N-acetylated amino acids, which is an important process in the metabolism of amino acids and, by extension, in cellular energy homeostasis. The chemicals listed above do not directly inhibit the enzyme but rather influence the metabolic pathways and cellular processes that ASPA3 is involved in or dependent upon for its function.
Acetate, for example, when in high concentrations, can compete with or saturate the enzymes involved in acetylation reactions, leading to a decrease in the availability of substrates that ASPA3 requires for its enzymatic activity. Hydroxylamine and aminooxyacetic acid are known to chemically modify enzyme substrates, which might reduce the efficiency with which ASPA3 can process its specific substrates. Compounds such as phenylacetate and sodium benzoate can conjugate with amino acids, thereby reducing the pool of acetylated amino acids available for deacetylation by ASPA3. On the other hand, inhibitors of metabolic pathways, such as 3-bromopyruvate, can disrupt energy production within the cell, leading to broader metabolic changes that may affect the activity of enzymes like ASPA3. Inhibition of glutamine synthetase by methionine sulfoximine or the action of azaserine and DON can disrupt nitrogen metabolism, which is intimately linked with amino acid metabolism and may thereby indirectly influence ASPA3's function
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acetic acid | 64-19-7 | sc-214462 sc-214462A | 500 ml 2.5 L | $63.00 $106.00 | 5 | |
Elevated levels of acetate can provide alternative acetylation substrates, potentially reducing the substrate availability for ASPA3. | ||||||
Hydroxylamine solution | 7803-49-8 | sc-250136 | 100 ml | $72.00 | ||
A chemical that can modify acyl-enzyme intermediates and might alter the reaction ASPA3 catalyzes by modifying its substrates. | ||||||
Azaserine | 115-02-6 | sc-29063 sc-29063A | 50 mg 250 mg | $312.00 $924.00 | 15 | |
An inhibitor of glutamine metabolism, potentially disrupting nitrogen balance and indirectly affecting ASPA3's activity. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $57.00 $245.00 $831.00 $1331.00 | 4 | |
A glutamine antagonist that can alter amino acid metabolism, potentially influencing ASPA3's activity in the cell. | ||||||
Riluzole | 1744-22-5 | sc-201081 sc-201081A sc-201081B sc-201081C | 20 mg 100 mg 1 g 25 g | $20.00 $193.00 $213.00 $317.00 | 1 | |
A drug that interferes with glutamic acid signaling, which may indirectly alter the metabolic environment of ASPA3. | ||||||
Sodium benzoate | 532-32-1 | sc-251009 | 250 g | $21.00 | ||
A compound that can conjugate with glycine, potentially reducing the bioavailability of acetylated substrates for ASPA3. | ||||||